Back

Proteomic signatures reveal why not all apolipoprotein B-containing lipoproteins are equal in atherosclerosis

31 August 2026 (15:18 - 15:30)
Organised by: Logo
Congress Presentation Part of: Metabolic risk scores and atherosclerotic cardiovascular disease Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jakub Morze

Chalmers University of Technology, Gothenburg (Sweden)

4 More presentations in this session

Presentation thumbnail
Association of Life's Essential 8 and psoriasis-atherosclerotic cardiovascular disease (PSO-ASCVD) comorbidity: a prospective cohort study
Doctor F. Tan (Beijing, CN)
Abstract
Presentation thumbnail
Combined elevation of lipoprotein(a) and polygenic risk in index patients identifies family members at high risk of coronary artery disease
Mr M. Annink (Amsterdam, NL)
Abstract
Presentation thumbnail
Association between lipoprotein(a) and ischemic brain lesions in patients with atrial fibrillation: insight from the Swiss-AF cohort
Doctor N. Johner (Bordeaux, FR)
Abstract
Presentation thumbnail
The metabolic score for insulin resistance (METS-IR) predicts MACE and is correlated to plasma levels of leptin and sRAGE: validation and mechanistic insights from a Swedish population-based cohort
Doctor F. Hammareus (Linkoping, SE)
Abstract

Access the full session

Session thumbnail
Metabolic risk scores and atherosclerotic cardiovascular disease

The Event

Event poster

ESC Congress 2026

31 August 2026 15:18 CET
You may be interested in
thumbnail
Congress Presentation
A proteomic atlas of atherosclerosis: regional proteomic signatures for plaque inflammation and calcification
30 April 2022
thumbnail
Congress Presentation
Discordance between LDL cholesterol and apolypoprotein B. Which to prefer to guide treatment?
13 April 2023
thumbnail
Congress Presentation
Low levels of apolipoprotein M are associated with increased risk of ventricular arrhythmias
2 September 2024
thumbnail
Congress Presentation
Genetic variants determining lipoprotein(a) predict early-onset myocardial infarction
15 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources